البحث | Friends - Best Social Network - החברים

Kan Kumar أضاف وظيفة جديدة أخرى
2025-07-02 12:30:31

Opportunities and Challenges in the Duchenne Muscular Dystrophy Therapeutics Market
Duchenne Muscular Dystrophy constitutes the most prevalent childhood muscular dystrophy, affecting approximately one in 3,500 male births globally. This devastating X-linked disorder results from dystrophin gene mutations that prevent normal muscle fiber maintenance, leading to progressive weakness, mobility loss, and premature mortality from cardiopulmonary complications. Recent therapeutic...

0 التعليقات 0 المشاركات 139 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Devidi Jahnavi أضاف وظيفة جديدة Health
2025-06-17 07:02:31

The Role of CRISPR and AAV in Duchenne Gene Repair
Duchenne Muscular Dystrophy (DMD) is a rare, progressive neuromuscular disorder that leads to severe muscle degeneration and early mortality. Affecting roughly 1 in 3,500 to 5,000 male births globally, DMD stems from mutations in the DMD gene, which encodes dystrophin, a protein critical for muscle fiber integrity. Without dystrophin, muscle cells become fragile and eventually die, leading to...

0 التعليقات 0 المشاركات 281 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Uttej Netha أضاف وظيفة جديدة Health
2025-07-01 04:53:54

High Therapy Costs Remain Barrier Despite Market Growth to USD 8.84B
The North America Duchenne Muscular Dystrophy (DMD) Treatment Market is set for significant growth, expanding from USD 2.06 billion in 2024 to USD 8.84 billion by 2033, at an impressive compound annual growth rate (CAGR) of 20.2% during the period 2025–2033. Download Sample Report:...

0 التعليقات 0 المشاركات 277 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!